Systems and methods for stimulation site selection
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61N-001/368
A61N-001/02
A61N-001/372
A61N-001/362
A61N-001/37
A61N-001/365
출원번호
US-0215074
(2016-07-20)
등록번호
US-10155116
(2018-12-18)
발명자
/ 주소
Yu, Yinghong
McDaniel, Martin
Humphrey, Jason
An, Qi
출원인 / 주소
Cardiac Pacemakers, Inc.
대리인 / 주소
Schwegman Lundberg & Woessner, P.A.
인용정보
피인용 횟수 :
0인용 특허 :
2
초록▼
Systems and methods for selecting one or more sites at or within at least one heart chamber for cardiac stimulation are disclosed. The system can include a physiologic sensor circuit to sense physiologic signals at two or more candidate stimulation sites. The system can generate respective activatio
Systems and methods for selecting one or more sites at or within at least one heart chamber for cardiac stimulation are disclosed. The system can include a physiologic sensor circuit to sense physiologic signals at two or more candidate stimulation sites. The system can generate respective activation timing indicators corresponding to the two or more candidate stimulation sites, and detect MI indicators indicating the presence of, or spatial proximity of each of the two or more candidate stimulation sites to a MI tissue. The system can use the activation timing indicators and the MI indicators to select at least one target stimulation site or to determine an electrostimulation vector. The system can display the selected target stimulation site to a user, or deliver electrostimulation to the patient at the target stimulation site or according to the determined electrostimulation vector.
대표청구항▼
1. A system, comprising: a physiologic sensor circuit, including a sense amplifier circuit to sense respective physiologic signals at three or more candidate stimulation sites at or within at least one chamber of a heart of a patient;an activation timer circuit, including a clock circuit coupled to
1. A system, comprising: a physiologic sensor circuit, including a sense amplifier circuit to sense respective physiologic signals at three or more candidate stimulation sites at or within at least one chamber of a heart of a patient;an activation timer circuit, including a clock circuit coupled to the physiologic sensor circuit to use the sensed respective physiologic signals to produce respective activation timing indicators corresponding to the three or more candidate stimulation sites;a myocardial infarction (MI) receiver circuit to receive respective MI indicators indicating relative spatial proximity of each of the three or more candidate stimulation sites to a MI tissue; anda stimulation site selector circuit, communicatively coupled to the activation timer circuit and the MI receiver circuit, configured to select a stimulation site from the three or more candidate stimulation sites associated with the respective MI indicators using the respective activation timing indicators and the respective MI indicators as the candidate stimulation site associated with and spatially more remote to the MI tissue than other of the three or more candidate stimulation sites. 2. The system of claim 1, comprising a therapy circuit configured to deliver electrostimulation to the patient using the selected stimulation site. 3. The system of claim 2, wherein: the stimulation site selector circuit is configured to select a first stimulation site and a different second stimulation site from the three or more candidate stimulation sites using the respective activation timing indicators and the respective MI indicators;the therapy circuit is configured to deliver the electrostimulation at the first and the second stimulation sites during a same cardiac cycle. 4. The system of claim 1, wherein: the physiologic sensor circuit is configured to sense the respective physiologic signals including cardiac electrical signals sensed at three or more left-ventricular (LV) candidate sites of the heart; andthe activation timer circuit is configured to determine the respective activation timing indicators including respective depolarization timings at the three or more LV candidate sites. 5. The system of claim 4, wherein the physiologic sensor circuit is configured to sense the cardiac electrical signals including intrinsic or evoked depolarizations at the three or more LV candidate sites, the evoked depolarizations produced in response to a stimulation of the heart. 6. The system of claim 4, wherein the activation timer circuit is configured to determine the respective depolarization timings including time intervals between a reference time and the respective depolarizations at the three or more LV candidate sites. 7. The system of claim 1, comprising a MI detector circuit, coupled to the physiologic sensor circuit, configured to detect the respective MI indicators at the three or more candidate stimulation sites using the respective physiologic signals including cardiac electrical signals at three or more LV candidate sites. 8. The system of claim 7, wherein the MI detector circuit includes a level detector circuit configured to determine, for each of the three or more LV candidate sites, an amplitude of the cardiac electrical signal sensed at the corresponding LV candidate site, wherein the MI detector circuit is configured to determine the relative spatial proximity to the MI tissue at the corresponding LV candidate site based on the corresponding amplitude of the cardiac electrical signal. 9. The system of claim 8, wherein the MI detector circuit includes a comparator circuit configured to compare the amplitudes of the cardiac electrical signals to a threshold, wherein the MI detector circuit is configured to detect, for each of the three or more LV candidate sites, a respective MI indicator as one of: a first indicator of being spatially proximal to a MI tissue if the determined amplitude falls below the threshold; ora second indication of being spatially remote to, or absence of, a MI tissue if the determined amplitude exceeds the threshold. 10. The system of claim 1, wherein the stimulation site selector is configured to select the stimulation site further associated with the respective activation timing indicator indicating a later activation than other of the three or more candidate stimulation sites. 11. The system of claim 1, wherein the stimulation site selector circuit is configured to generate a selectable set of candidate electrostimulation vectors including an electrode positioned at the selected stimulation site. 12. The system of claim 1, further comprising: a secondary indicator generation circuit configured to generate one or more second indicators indicative of one of therapy efficacy, battery longevity, or complication of stimulation; anda user interface that enables a user to perform one of more of:ranking at least some of the candidate electrostimulation vectors according to an order of the MI indicators or the one or more second indicators;selecting at least one target electrostimulation vector from the candidate electrostimulation vectors; orprogramming an electrostimulation therapy for delivery at the heart according to the selected at least one target electrostimulation vector. 13. A system, comprising: a physiologic sensor circuit, including a sense amplifier circuit to sense cardiac electrical signals at three or more candidate stimulation sites in a left ventricle (LV) of a heart of a patient;an activation timer circuit, including a clock circuit coupled to the physiologic sensor circuit to use the sensed cardiac electrical signals to produce respective activation timing indicators corresponding to the three or more LV candidate sites;a myocardial infarction (MI) detector circuit, including:a level detector circuit configured to determine, for each of the three or more LV candidate sites, a relative spatial proximity to MI tissue based on an amplitude of the cardiac electrical signal sensed at the corresponding LV candidate site; anda comparator circuit configured to compare the amplitudes of the cardiac electrical signals to a threshold to detect, for each of the three or more LV candidate sites, a respective MI indicator as one of a first indicator of being spatially proximal to a MI tissue if the determined amplitude falls below the threshold, or a second indication of being spatially remote to, or absence of, a MI tissue if the determined amplitude exceeds the threshold;a stimulation site selector circuit configured to select at least one stimulation site from the three or more candidate stimulation sites associated with the respective MI indicators using (1) a respective activation timing indicator indicating a later activation than other of the three or more candidate stimulation sites, and (2) a respective MI indicator indicating spatially more remote to a MI tissue than other of the three or more candidate stimulation sites, the selected at least one stimulation site associated with the MI tissue; anda therapy circuit, configured to deliver electrostimulation to the patient using the selected at least one stimulation site. 14. A method, comprising: sensing, at three or more candidate stimulation sites at or within at least one chamber of a heart of a patient, respective physiologic signals;determining respective activation timing indicators corresponding to the three or more candidate stimulation sites by using the sensed respective physiologic signals;detecting respective myocardial infarction (MI) indicators indicating relative spatial proximity of each of the three or more candidate stimulation sites to, a MI tissue; andselecting a stimulation site from the three or more candidate stimulation sites associated with the respective MI indicators using the respective activation timing indicators and the respective MI indicators as the candidate stimulation site associated with and spatially more remote to the MI tissue than other of the three or more candidate stimulation sites. 15. The method of claim 14, further comprising delivering electrostimulation using the selected stimulation site. 16. The method of claim 15, comprising: selecting at least a first stimulation site and a different second stimulation site from the three or more candidate stimulation sites using the respective activation timing indicators and the respective MI indicators; anddelivering the electrostimulation includes delivering respective electrostimulation at the first and the second stimulation sites during a same cardiac cycle. 17. The method of claim 14, wherein: sensing the respective physiologic signals includes sensing cardiac electrical signals at three or more left-ventricular (LV) candidate sites of the heart; anddetermining the respective activation timing indicators includes determining respective depolarization timings at the three or more LV candidate sites. 18. The method of claim 14, wherein: sensing the respective physiologic signals includes sensing cardiac electrical signals at three or more left-ventricular (LV) candidate sites of the heart;determining the respective MI indicators includes:determining the relative spatial proximity to the MI tissue based on amplitudes of the cardiac electrical signals sensed at the three or more LV candidate sites; anddetecting, for each of the three or more LV candidate sites, a respective MI indicator as one of a first indicator of being spatially proximal to a MI tissue if the amplitude falls below a threshold, or a second indication of being spatially remote to, or absence of, a MI tissue if the amplitude exceeds the threshold. 19. The method of claim 14, wherein the selected stimulation site is further associated with an activation timing indicator indicating a later activation than other of the three or more candidate stimulation sites. 20. The method of claim 14, further comprising: generate one or more second indicators indicative of one of therapy efficacy, battery longevity, or complication of stimulation;generating a selectable set of candidate electrostimulation vectors including an electrode positioned at the selected stimulation site; andranking, automatically or based on a user input, at least some of the candidate electrostimulation vectors according to an order of the MI indicators or the one or more second indicators.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (2)
Gandhi, Rajesh Krishan; Linder, William J.; Lyden, Michael J.; Stessman, Nicholas J.; Kelly, Jonathan H.; Kalgren, James, Dynamic battery management in an implantable device.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.